Asterias Biotherapeutics, Inc. (ASTY) is a publicly traded company in the Unknown sector. Across all available filings, 2 corporate insiders have executed 7 transactions totaling $922.4K, demonstrating a bullish sentiment with $922.4K in net insider flow. The most recent transaction on Oct 1, 2014 involved a purchase of 50,000 shares valued at $298.5K.
No significant insider buying has been recorded for ASTY in the recent period.
No significant insider selling has been recorded for ASTY in the recent period.
Based on recent SEC filings, insider sentiment for ASTY is bullish with an Insider Alignment Score of 100/100 and a net flow of $922.4K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Asterias Biotherapeutics, Inc. (ASTY) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 2 insiders are actively trading ASTY stock, having executed 7 transactions in the past 90 days. The most active insider is Equities Llc Scarsdale (Executive), who has made 6 transactions totaling $922.4K.
Get notified when executives and directors at ASTY file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 1, 2014 | Llc Scarsdale Equities | Executive | Purchase | 50,000 | $5.97 | $298.5K | |
| Sep 29, 2014 | Llc Scarsdale Equities | Executive | Purchase | 10,000 | $5.73 | $57.3K | |
| Sep 24, 2014 | Llc Scarsdale Equities | Executive | Purchase | 10,000 | $5.35 | $53.5K | |
| Sep 23, 2014 | Llc Scarsdale Equities | Executive | Purchase | 15,000 | $4.58 | $68.7K | |
| Sep 5, 2014 | Llc Scarsdale Equities | Executive | Purchase | 30,000 | $5.48 | $164.4K | |
| Sep 4, 2014 | Llc Scarsdale Equities | Executive | Purchase | 70,000 | $4.00 | $280.0K | |
| Aug 18, 2014 | Lebkowski Jane | Executive | Other | 476 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 6 | $922.4K | 100.0% |
Other(J) | 1 | $0 | 0.0% |
Insiders at Asterias Biotherapeutics, Inc. are accumulating shares at an accelerated pace. With 2 insiders making 7 transactions totaling $922.4K in purchases versus $0 in sales, the net buying activity of $922.4K signals strong executive confidence. Equities Llc Scarsdale (Executive) leads the buying activity with $922.4K in transactions across all time.